SCHEMBL5079703

SCHEMBL5079703

CC(C)(C)CC(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 6/20 0.52
HTR2A P28223 5/20 0.52
RIPK1 Q13546 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
CACNA1F O60840 1/20 0.47
CHRM2 P08172 1/20 0.47
CHRM1 P11229 1/20 0.47
ADRA2B P18089 1/20 0.47
CHRM3 P20309 1/20 0.47
ADRA1A P35348 1/20 0.47
OPRK1 P41145 1/20 0.47
CACNA1D Q01668 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KCNH2 Q12809 1/20 0.47
CACNA1S Q13698 1/20 0.47
CACNA1C Q13936 1/20 0.47
SCN5A Q14524 1/20 0.47
TAAR1 Q96RJ0 4/20 0.46
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11162583 0.82 HIF1A (0.45) HTR2ARIPK1ADRA2BADRA1AOPRK1
SCHEMBL5664123 0.80 RIPK1 (0.63) HRH1HTR2ARIPK1TDP1CACNA1F
SCHEMBL5046280 0.80 TAAR1 (0.48) HRH1HTR2ARIPK1TDP1CACNA1F
SCHEMBL416116 0.80 RIPK1 (0.45) HRH1HTR2ARIPK1TDP1CACNA1F
SCHEMBL16291590 0.78 SCN4A (0.45) RIPK1
SCHEMBL5461547 0.78 SCN4A (0.45) RIPK1
SCHEMBL12435669 0.78 RIPK1 (0.64) RIPK1SLC6A3LMNAKDM4EMEN1
SCHEMBL11654729 0.78 RIPK1 (0.45) HRH1HTR2ARIPK1TDP1CACNA1F
SCHEMBL5163930 0.78 RIPK1 (0.64) RIPK1SLC6A3LMNAKDM4EMEN1
SCHEMBL11691420 0.78 RIPK1 (0.45) HRH1HTR2ARIPK1TDP1CACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004715-A2 METHOD TO PREPARE BLOCK COPOLYMERS BY THE COMBINATION OF CATIONIC AND ANIONIC POLYMERIZATION UNIVERSITY OF MASSACHUSETTS LOWELL (US) 2008-12-24 EP claimed
WO-2007117566-A2 METHOD TO PREPARE BLOCK COPOLYMERS BY THE COMBINATION OF CATIONIC AND ANIONIC POLYMERIZATION UNIVERSITY OF MASSACHUSETTS LOWELL (US) 2007-10-18 WO claimed
US-12043621-B2 Small molecule inhibitors of Interleukin-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2024-07-23 US disclosed
CN-114606519-B Olefin hydroalkylation reaction method based on electrochemical means and CuX catalysis 天津理工大学 2024-05-28 CN disclosed
US-11760715-B2 Modulators of lipoxygenase and cyclooxygenase enzyme activity UNIVERSITÉ DE MONCTON (CA) 2023-09-19 US disclosed
CN-114606519-A Olefin hydroalkylation reaction method based on electrochemical means and CuX catalysis 天津理工大学 2022-06-10 CN disclosed
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2021-10-14 US disclosed
EP-2004715-A2 METHOD TO PREPARE BLOCK COPOLYMERS BY THE COMBINATION OF CATIONIC AND ANIONIC POLYMERIZATION UNIVERSITY OF MASSACHUSETTS LOWELL (US) 2008-12-24 EP disclosed
WO-2007117566-A2 METHOD TO PREPARE BLOCK COPOLYMERS BY THE COMBINATION OF CATIONIC AND ANIONIC POLYMERIZATION UNIVERSITY OF MASSACHUSETTS LOWELL (US) 2007-10-18 WO disclosed
EP-0832158-B1 GELS MADE FROM TRIBLOCK COPOLYMERS RAYCHEM LTD (GB) 1999-12-01 EP disclosed
US-5994446-A METHACRYLATE-ALKYLENE(HYDROGENATED OR UNHYDROGENATED)-METHACRYLATE TRIBLOCK COPOLYMER HAVING NUMBER AVERAGE MOLECULAR WEIGHT MN OF AT LEAST 50,000 AND AT LEAST 200 PARTS BY WEIGHT OF EXTENDER LIQUID WEIGHT OF THE TRIBLOCK RAYCHEM LIMITED (GB) 1999-11-30 US disclosed
US-5180799-A Organolithium-Organoaluminum Catalyst IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-01-19 US disclosed
EP-0434316-A1 Processes ZENECA LIMITED (GB) 1991-06-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760715-B2 Modulators of lipoxygenase and cyclooxygenase enzyme activity ALOX12, ALOX15B, ALOX5 HRH1 1573/4885HTR2A 431/4885RIPK1 2240/4885
US-12043621-B2 Small molecule inhibitors of Interleukin-4 IL4, IL2, IL4I1 HRH1 1930/4885HTR2A 4606/4885RIPK1 863/4885
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 IL4, IL2, IL4I1 HRH1 1930/4885HTR2A 4606/4885RIPK1 863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.